Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic/Recurrent Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01151449
What this trial is testing

Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerMale Breast Cancer+7 more
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)UnknownNCT05546255
What this trial is testing

Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT04085276
What this trial is testing

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

Who this might be right for
Triple-Negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd. 531
Testing effectiveness (Phase 2)Ended earlyNCT01290718
What this trial is testing

Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 4
Testing effectiveness (Phase 2)Study completedNCT00031876
What this trial is testing

Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933
What this trial is testing

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more
National Cancer Institute (NCI) 81
Large-scale testing (Phase 3)Study completedNCT00044291
What this trial is testing

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-dependent
Intarcia Therapeutics 865
Not applicableLooking for participantsNCT06358625
What this trial is testing

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Center Eugene Marquis 120
Early research (Phase 1)Study completedNCT00637897
What this trial is testing

Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 24
Not applicableLooking for participantsNCT06217874
What this trial is testing

Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer

Who this might be right for
Breast CarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma
Mayo Clinic 2,000
Testing effectiveness (Phase 2)UnknownNCT00687648
What this trial is testing

Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Centre, Singapore 70
Testing effectiveness (Phase 2)Ended earlyNCT01938833
What this trial is testing

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Who this might be right for
HER2-negative Breast CancerInflammatory Breast CancerMale Breast Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Testing effectiveness (Phase 2)Study completedNCT00733408
What this trial is testing

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+3 more
University of Washington 59
Testing effectiveness (Phase 2)Study completedNCT02048059
What this trial is testing

ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases

Who this might be right for
Breast CancerBrain Metastases
Angiochem Inc 72
Testing effectiveness (Phase 2)Ended earlyNCT00784524
What this trial is testing

Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Looking for participantsNCT05440227
What this trial is testing

PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients

Who this might be right for
Cancer-related Fatigue
PhytoHealth Corporation 36
Testing effectiveness (Phase 2)Study completedNCT00004013
What this trial is testing

Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)UnknownNCT00072020
What this trial is testing

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast CancerMetastatic Cancer
University of Sheffield
Testing effectiveness (Phase 2)Study completedNCT00077376
What this trial is testing

Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more
National Cancer Institute (NCI) 61
Next Page